COMMUNIQUÉS West-GlobeNewswire

Nexstim Plc: Amendment of stock option programs
10/06/2019
Company announcement, Helsinki, 10 June 2019 at 3.00 PM Nexstim Plc: Amendment of stock option programs Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( "Nexstim" or "Company" ), the targeted neuromodulation company developing and [...]
Shockwave Appoints Hajime Tada as General Counsel
10/06/2019
SANTA CLARA, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Tabula Rasa HealthCare’s Dr. Sandra Leal is President-elect American Pharmacists Association
10/06/2019
CEO of SinfoníaRx, a TRHC subsidiary, will lead the advancement of the Pharmacy profession as APhA President in 2021 MOORESTOWN, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: [...]
GBT Awards More than $200,000 in Grants to Five Nonprofit Organizations through New ACCEL Program Aimed at Improving Access to Healthcare for People Living with Sickle Cell Disease
10/06/2019
Company Created ACCEL (Access to Excellent Care for Sickle Cell Patients Pilot Program) to Accelerate Development of Innovative Healthcare Programs for Sickle Cell Community SOUTH SAN FRANCISCO, Calif., June 10, 2019 ( [...]
Altimmune Announces Successful Pre-IND Meeting with FDA
10/06/2019
Meeting on HepTcell Phase 2 program for treatment of chronic hepatitis B (HBV) GAITHERSBURG, Md., June 10, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today [...]
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
10/06/2019
The new patent expands the robust patent portfolio covering RHB-104 and RHB-204 RedHill plans to initiate a pivotal Phase 3 study with RHB-204 for the treatment of pulmonary nontuberculous mycobacteria (NTM) infections [...]
Oncternal Therapeutics Completes Reverse Merger with GTx, Inc.
10/06/2019
Shares of Oncternal to commence trading on Nasdaq under new ticker symbol ONCT on June 10, 2019 SAN DIEGO, June 10, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., (Nasdaq: ONCT) a clinical-stage biotechnology [...]
IntelGenx Announces Addition of Ottawa Montelukast VersaFilm® Phase 2a Clinical Trial Site; First Patient in Study Completes 26-Week Treatment
10/06/2019
SAINT LAURENT, Quebec, June 10, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), leader in pharmaceutical films, today announced that it has added a new Ottawa site in the Montelukast [...]
Entasis Therapeutics Announces Oral and Poster Presentations of its Pathogen-Targeted Antibiotic Clinical Programs at ASM Microbe 2019
10/06/2019
WALTHAM, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
10/06/2019
NEWTOWN, Pa., June 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial [...]
Artizan Biosciences Announces Corporate Progress and Financing
10/06/2019
Finalized Series A funding, bringing total raised to date to $12MM to support proprietary platform that enables identification of disease-driving bacteria and development of therapies for inflammatory diseases Appointed [...]
T2 Biosystems Reports Granting of Inducement Awards
10/06/2019
LEXINGTON, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities
10/06/2019
Company to Facilitate Transaction Process and Sale of Substantially All Assets Through Chapter 11 of the U.S. Bankruptcy Code Operations to Continue as Normal Including Payment of Employee Wages and Benefits and [...]
Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares
10/06/2019
ANN ARBOR, Mich., June 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced that it [...]
Aleafia Health Secures Outdoor Cultivation Licence, Commences Planting of First Outdoor Crop
10/06/2019
13,000 Starter Clones Already on-site at Port Perry Facility First Crop Underway With Plants now in the Ground Company’s Licensed Cultivation Area Increases from 22,000 sq. ft. to 314,000 sq. ft. Facility Expected to [...]
Issue of Equity on Exercise of Options
10/06/2019
Cambridge, UK and Indianapolis, US – 10 June 2018: Acacia Pharma Group plc (the "Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting [...]
MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predictive Value and Sensitivity
10/06/2019
Multi-center 1,955 patient study published in the Journal of Urology IRVINE, CA, and HERSTAL, BELGIUM - Jun 10, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today [...]
MDxHealth (R) :
10/06/2019
Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.
10/06/2019
Basel, 10 June 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that they have each received a request for additional information and documentary material ( [...]

Pages